Psoriasis and Dyslipidaemia: A Population-based Study

被引:63
作者
Dreiher, Jacob [1 ,2 ]
Weitzman, Dahlia [3 ]
Davidovici, Batya [4 ]
Shapiro, Jonathan [5 ]
Cohen, Arnon D. [1 ,6 ]
机构
[1] Ben Gurion Univ Negev, Siaal Res Ctr Family Med & Primary Care, Fac Hlth Sci, IL-84150 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Clalit Hlth Serv, Fac Hlth Sci, IL-84150 Beer Sheva, Israel
[3] Ben Gurion Univ Negev, Dept Epidemiol, Fac Hlth Sci, IL-84150 Beer Sheva, Israel
[4] Kaplan Med Ctr, Dermatol Unit, Rehovot, Israel
[5] Rabin Med Ctr, Dept Dermatol, Petah Tiqwa, Israel
[6] Clalit Hlth Serv, Res & Hlth Planning Dept, Hlth Planning & Policy Wing, Tel Aviv, Israel
关键词
dyslipidaemia; hyperlipidaemia; psoriasis; lipid levels; cholesterol; triglycerides; metabolic syndrome;
D O I
10.2340/00015555-0510
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Previous reports demonstrated an association between psoriasis and the metabolic syndrome. The aim of this study was to elucidate the association between psoriasis and dyslipidaemia. A cross-sectional study was performed utilizing a population-based database. Psoriasis patients were compared with enrollees without psoriasis regarding the prevalence of dyslipidaemia and lipid levels. Comparison of lipid levels was performed on a "low-risk" subset of subjects without diabetes, hypertension and cardiovascular disease. The study included 10,669 psoriasis patients and 22,996 subjects without psoriasis. The prevalence of dyslipidaemia was significantly higher in psoriasis patients (odds ratio (OR)=1.48, 95% confidence interval (CI) 1.40-1.55). The association remained significant after controlling for confounders (OR=1.19, 95% CI 1.12-1.26, p < 0.001). In multivariate analysis of the "low-risk" subset, triglyceride levels were higher in psoriasis patients and high-density lipoprotein cholesterol levels were lower. This study supports previous reports of an association between psoriasis and lipid abnormalities.
引用
收藏
页码:561 / 565
页数:5
相关论文
共 27 条
[11]   Metabolic disorders in patients with psoriasis and psoriatic arthritis [J].
Mallbris L. ;
Ritchlin C.T. ;
Ståhle M. .
Current Rheumatology Reports, 2006, 8 (5) :355-363
[12]   Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case-control study [J].
Naldi, L ;
Chatenoud, L ;
Linder, D ;
Fortina, AB ;
Peserico, A ;
Virgili, AR ;
Bruni, PL ;
Ingordo, V ;
Lo Scocco, G ;
Solaroli, C ;
Schena, D ;
Barba, A ;
Di Landro, A ;
Pezzarossa, E ;
Arcangeli, F ;
Gianni, C ;
Betti, R ;
Carli, P ;
Farris, A ;
Barabino, GF ;
La Vecchia, C .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (01) :61-67
[13]  
National Cholesterol Education Program (NCEP), 2002, NIH PUBL
[14]   Prevalence of cardiovascular risk factors in patients with psoriasis [J].
Neimann, Andrea L. ;
Shin, Daniel B. ;
Wang, Xingmei ;
Margolis, David J. ;
Troxel, Andrea B. ;
Gelfand, Joel M. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (05) :829-835
[15]   The comorbid state of psoriasis patients in a university dermatology practice [J].
Pearce, DJ ;
Morrison, AE ;
Higgins, KB ;
Crane, MM ;
Balkrishnan, R ;
Fleischer, AB ;
Feldman, SR .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2005, 16 (5-6) :319-323
[16]  
Pietrzak Aldona, 2002, Med Sci Monit, V8, pCR9
[17]   Serum lipid levels in psoriasis [J].
Piskin, S ;
Gurkok, F ;
Ekuklu, G ;
Senol, M .
YONSEI MEDICAL JOURNAL, 2003, 44 (01) :24-26
[18]  
Rennert G, 2001, ISR MED ASSOC J, V3, P404
[19]   Lipid profile, insulin secretion, and insulin sensitivity in psoriasis [J].
Reynoso-von Drateln, C ;
Martínez-Abundis, E ;
Balcázar-Muñoz, BR ;
Bustos-Saldaña, R ;
González-Ortiz, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (06) :882-885
[20]   Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease [J].
Rocha-Pereira, P ;
Santos-Silva, A ;
Rebelo, I ;
Figueiredo, A ;
Quintanilha, A ;
Teixeira, F .
CLINICA CHIMICA ACTA, 2001, 303 (1-2) :33-39